Moody National Bank Trust Division Biocryst Pharmaceuticals Inc Transaction History
Moody National Bank Trust Division
- $922 Million
- Q3 2024
A detailed history of Moody National Bank Trust Division transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Moody National Bank Trust Division holds 60,370 shares of BCRX stock, worth $452,171. This represents 0.05% of its overall portfolio holdings.
Number of Shares
60,370
Previous 52,046
15.99%
Holding current value
$452,171
Previous $321,000
42.68%
% of portfolio
0.05%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding BCRX
# of Institutions
280Shares Held
172MCall Options Held
625KPut Options Held
739K-
Vanguard Group Inc Valley Forge, PA20.3MShares$152 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$149 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$88.9 Million1.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$68 Million5.66% of portfolio
-
State Street Corp Boston, MA8.85MShares$66.3 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.39B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...